1,578
Views
20
CrossRef citations to date
0
Altmetric
Articles

Comparative study of the essential oil composition of Salvia urmiensis and its enzyme inhibitory activities linked to diabetes mellitus and Alzheimer’s disease

ORCID Icon, &
Pages 2974-2981 | Received 11 Aug 2016, Accepted 19 Nov 2016, Published online: 22 May 2017
 

ABSTRACT

The genus Salvia has economic importance due to its broad uses in traditional medicine, perfume, food, and pharmaceutical industries. In the present work, various extracts and essential oils of Salvia urmiensis Bunge., were screened for their inhibitory activity against acetylcholinesterase and butyrylcholinesterase, the enzymes linked to neurodegeneration, and against α-amylase and α-glucosidase (involved in diabetes mellitus; DM). Chemical compositions of the essential oils of leaves and flowers of the plant were also determined. The tested samples exhibited moderate to high anti-diabetic potential (IC50 = 8–145 µg/mL) and moderate anticholinesterase activity (IC50 = 44–892 µg/mL). Essential oil of leaves was rich in ester compounds such as ethyl linoleate (19%), methyl hexadecanoate (17%), and methyl linoleate (7.5%). The major compound of essential oil of flowers was 6,10,14-trimethyl-2-pentadecanone (55.7%). This is the first report on the enzyme inhibitory activity of S. urmiensis and also the chemical composition of its leaves and flowers in essential oils. The results indicated that S. urmiensis could be considered a valuable source for functional foods and pharmaceuticals.

Acknowledgments

Financial support by the Shahid Beheshti University Research Council is gratefully acknowledged.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.